[HTML][HTML] Recent advances in long-acting drug delivery systems for anticancer drug
The use of systemic anticancer chemotherapy is intrinsically limited by its toxicity. Whether
dealing with small molecules or biopharmaceuticals, after systemic administration, small …
dealing with small molecules or biopharmaceuticals, after systemic administration, small …
Applications of chitin and chitosan nanofibers in bone regenerative engineering
F Tao, Y Cheng, X Shi, H Zheng, Y Du, W Xiang… - Carbohydrate …, 2020 - Elsevier
Promoting bone regeneration and repairing defects are urgent and critical challenges in
orthopedic clinical practice. Research on bone substitute biomaterials is essential for …
orthopedic clinical practice. Research on bone substitute biomaterials is essential for …
[HTML][HTML] Mussel-inspired agarose hydrogel scaffolds for skin tissue engineering
T Su, M Zhang, Q Zeng, W Pan, Y Huang, Y Qian… - Bioactive materials, 2021 - Elsevier
Polysaccharide hydrogels are widely used in tissue engineering because of their superior
biocompatibility and low immunogenicity. However, many of these hydrogels are unrealistic …
biocompatibility and low immunogenicity. However, many of these hydrogels are unrealistic …
Recent advances in natural polymer-based drug delivery systems
Natural polymers have been extensively explored as the vehicles for encapsulation and
delivery of drugs and other bioactive molecules, which have attracted tremendous attention …
delivery of drugs and other bioactive molecules, which have attracted tremendous attention …
Synthesis, molecular features and biological activities of modified plant polysaccharides
S Mukherjee, S Jana, S Khawas, J Kicuntod… - Carbohydrate …, 2022 - Elsevier
Plant polysaccharides represent a natural source material characterized by high ubiquity,
abundance and biological activities that can be utilised as organic matter in numerous …
abundance and biological activities that can be utilised as organic matter in numerous …
Chitosan: A versatile bio-platform for breast cancer theranostics
VS Madamsetty, S Tavakol, S Moghassemi… - Journal of Controlled …, 2022 - Elsevier
Breast cancer is considered one of the utmost neoplastic diseases globally, with a high
death rate of patients. Over the last decades, many approaches have been studied to early …
death rate of patients. Over the last decades, many approaches have been studied to early …
Chitosans and nanochitosans: recent advances in skin protection, regeneration, and repair
Chitosan displays a dual function, acting as both an active ingredient and/or carrier for
pharmaceutical bioactive molecules and metal ions. Its hydroxyl-and amino-reactive groups …
pharmaceutical bioactive molecules and metal ions. Its hydroxyl-and amino-reactive groups …
[HTML][HTML] Not only in silico drug discovery: Molecular modeling towards in silico drug delivery formulations
T Casalini - Journal of Controlled Release, 2021 - Elsevier
The use of methods at molecular scale for the discovery of new potential active ligands, as
well as previously unknown binding sites for target proteins, is now an established reality …
well as previously unknown binding sites for target proteins, is now an established reality …
[PDF][PDF] Chitosan-functionalized bioplatforms and hydrogels in breast cancer: immunotherapy, phototherapy and clinical perspectives
T Li, M Ashrafizadeh, Y Shang, Y Nuri Ertas… - Drug Discov …, 2024 - researchgate.net
The incidence rate of breast cancer in women is high, and this has caused a significant
health problem for society and public health providers.(p1) The epidemiological data …
health problem for society and public health providers.(p1) The epidemiological data …
Photocurable chitosan as bioink for cellularized therapies towards personalized scaffold architecture
C Tonda-Turo, I Carmagnola, A Chiappone, Z Feng… - Bioprinting, 2020 - Elsevier
Recent progresses in tissue engineering are directed towards the development of
technologies able to provide personalized scaffolds recreating the defect shape in a patient …
technologies able to provide personalized scaffolds recreating the defect shape in a patient …